David
Santamaría Velilla
Massachusetts Institute of Technology
Cambridge, Estados UnidosPublicaciones en colaboración con investigadores/as de Massachusetts Institute of Technology (2)
2014
-
Lentiviral-based approach for the validation of cancer therapeutic targets in vivo
BioTechniques, Vol. 57, Núm. 4, pp. 179-187
2010
-
A Synthetic Lethal Interaction between K-Ras Oncogenes and Cdk4 Unveils a Therapeutic Strategy for Non-small Cell Lung Carcinoma
Cancer Cell, Vol. 18, Núm. 1, pp. 63-73